Vitiligo Therapy
Vitiligo is a chronic autoimmune condition in which the loss of melanocytes disrupts skin pigmentation. Stem cell therapy targets melanocyte renewal, immune rebalancing, and accelerated repigmentation.
Therapy Process
Dermatological Assessment
Lesion mapping, Wood's lamp analysis, autoimmune marker panel and blood tests.
Stem Cell Preparation
Mesenchymal stem cells are dosed according to the patient's individual profile and optimised for immunomodulatory effect.
Therapy Protocol
IV stem cell infusion combined, where indicated, with local intradermal application to lesion areas.
Long-Term Follow-Up
Repigmentation assessment at months 3 and 6, phototherapy integration support and dermatologist review.
- ✓Support for melanocyte renewal
- ✓Accelerated repigmentation process
- ✓Suppression of autoimmune activity
- ✓Slowing of lesion spread
- ✓Overall improvement in skin health
Frequently Asked Questions
Who Is This Therapy For?
✓Suitable Candidates
- •Adults with segmental or stable vitiligo
- •Patients who have not responded adequately to conventional treatments
- •Patients in a stable phase with no active spreading
✕Not Suitable For
- •Those experiencing an active autoimmune flare
- •Those undergoing active cancer treatment
- •Those with blood clotting disorders
Therapy Timeline
Remote Assessment
1–2 weeks: dermatological photos, autoimmune marker panel and blood tests
Istanbul Programme
2–3 days: IV stem cell infusion and local intradermal application where indicated
Long-Term Follow-Up
6 months: repigmentation assessment at months 3 and 6, phototherapy integration support
Want to get information right now?
Our specialists answer your questions via WhatsApp.